Dexcom opens up CGM data to app developers amid transition from receiver to smartphone
Dexcom Inc. has made available a public application programming interface (API) to enable open-source app development based on data from its continuous glucose monitor (CGM) system data. The move comes as more of the patients using the system are adopting a smartphone, rather than a dedicated reader, which makes the CGM data more accessible.
Columbia researchers reveal novel technique to link 'dark genome' to genetic diseases
Elucidating the role of genetics in understanding disease is a driving force for the diagnostic and biopharmaceutical industries. But, until now, much of the human genome has remained largely a mystery. Scientists have long focused on the portion that codes for proteins but that represents only 2 percent of the human genome. Researchers at Columbia University Medical Center have developed a new technique, known as Orion, which interrogates the noncoding 98 percent, the so-called 'dark genome.'
Apollo endosurgery clarifies FDA letter on intragastric balloon safety
Following an FDA letter issued Thursday Aug. 10 to health care providers about possible risks with liquid-filled intragastric balloons, Apollo Endosurgery Inc. held a call on Friday to address the letter. During the call, executives with Apollo, maker of the Orbera intragastric balloon system, discussed the FDA letter regarding unexpected deaths of five patients who had received the balloons, though their deaths were not determined to be the result of the devices, said the company.